IMKELDI (imatinib oral)

**Product type:** Human Prescription Drug

**Active ingredient:** IMATINIB MESYLATE

**Strength:** 80 mg/mL

**Dosage form:** Solution

**Route:** Oral

**Labeler:** Shorla Oncology Inc.,

**Marketing category:** NDA (NDA219097)

**Pharmacologic class:** Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]